VA Puget Sound Health Care System, University of Washington School of Medicine, Seattle, Washington, USA.
University of Washington School of Medicine, Seattle, Washington, USA.
Am J Gastroenterol. 2019 Aug;114(8):1199-1201. doi: 10.14309/ajg.0000000000000307.
The adenoma detection rate (ADR) is our current best colonoscopy quality indicator, but it is not without limitations. In this issue of the Journal, novel ADR benchmarks are proposed based on historical local colonoscopy results. These minimally acceptable, standard of care, and aspirational benchmarks may encourage continuous quality improvement through the explicit determination of notably higher but proven achievable ADR targets, although validation in clinical practice is needed. Ultimately, we must transition from ADR measurement to the implementation of robust quality improvement processes that assure the best outcomes for our patients.
腺瘤检出率(ADR)是我们目前最好的结肠镜质量指标,但它并非没有局限性。在本期杂志中,基于当地历史结肠镜检查结果,提出了新的 ADR 基准。这些可接受的最低标准、标准护理和期望的基准可能通过明确确定明显更高但已证明可实现的 ADR 目标来鼓励持续的质量改进,尽管需要在临床实践中进行验证。最终,我们必须从 ADR 测量过渡到实施强大的质量改进流程,以确保为患者提供最佳结果。